Xishan Biotechnology _Experimental animal quality testing

Historical Search

Clear historical searches

Common Searches

测试

试剂

中

CMA-accredited and CNAS-accredited third-party testing laboratories<br />Fairness, science, accuracy, efficiency

CMA-accredited and CNAS-accredited third-party testing laboratories
Fairness, science, accuracy, efficiency View More

scroll down

Xishan Biology

China's Leader in Experimental Animal Quality Testing

Suzhou Xishan Biotechnology Co., Ltd., as the first independent third-party testing organization in Asia dedicated to laboratory animal quality control, has successfully achieved triple accreditation: CNAS (China National Accreditation Service for Conformity Assessment), CMA (Certification of Competence), and ISO 9001 Quality Management System. Additionally, the company has obtained BSL-2 level biosafety laboratory registration approval. The company’s comprehensive network of testing services and reagent sales spans 16 countries and regions across Asia, Europe, North America, and Southeast Asia, serving over 1,600 research institutions, biopharmaceutical companies, laboratory animal production facilities, customs agencies, and animal quality control stations worldwide—providing professional, internationally compliant testing services and reagent solutions tailored to their specific needs.

20 year

Industry Experience

16 +

Countries and Regions

1600 +

Customer

1 million+

Test sample

Providing integrated solutions encompassing testing services, reagent development, and technology innovation

Testing Services

Equipped with laboratories in immunology, molecular biology, microbiology, and pathology testing, we offer comprehensive diagnostic services for viruses, bacteria, parasites, pathological conditions, genetics, as well as environmental pathogens found in experimental animals, pets, and economically important livestock—covering both the animals themselves and samples from their living environments and rearing facilities.

Reagent Center

We have independently developed the VRL brand line of experimental animal pathogen detection kits, offering a comprehensive product portfolio that covers rodents, non-human primates, dogs, cats, and other commonly used lab animals. Our reagents boast superior sensitivity, specificity, and batch-to-batch consistency compared to industry-standard products, ensuring reliable quality control for experimental animals. Additionally, we are the exclusive distributor of the U.S.-based XPRESSBIO brand, providing customers with an even broader range of cutting-edge experimental animal testing kits.

New drug clinical trials

Building an industry-leading inspection and diagnostic technology system, supported by a multidisciplinary technology platform, to deliver comprehensive testing services across all fields. We have extensive experience in projects such as clinical strain verification and identification for antimicrobial and antiviral drugs, as well as adenovirus detection.

Multi-factor authentication ensures the company's professional expertise and service quality.

CNAS Accredited
International Mutual Recognition

In 2011, it was accredited by the China National Accreditation Service for Conformity Assessment (CNAS), with the mission of enhancing acceptance of testing and calibration results issued by accredited laboratories, thereby helping to remove technical trade barriers and fostering international cooperation in promoting global trade.

CMA Certification
Laboratory Accreditation

In 2014, the company obtained CMA accreditation from the Jiangsu Provincial Bureau of Quality and Technical Supervision. Over the years, it has consistently participated in proficiency testing programs with satisfactory results, ensuring the high quality of both its technical capabilities and services.

ISO 9001 Certification

Achieved ISO 9001 Quality Management System Certification in 2021

News and Information

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

2024-09

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

2024-08

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.

2024-03

On March 1, 2024, experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited for an inspection. Our company successfully passed the qualification review for Jiangsu Province's certification as a quarantine and testing laboratory specializing in dogs and cats at their place of origin.